Nicolas Beaudet
Overview
Explore the profile of Nicolas Beaudet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sasseville M, Supper W, Gartner J, Layani G, Amil S, Sheffield P, et al.
JMIR Res Protoc
. 2023 Aug;
12:e48155.
PMID: 37594780
Background: Health measurement guides policies and health care decisions are necessary to describe and attain the quintuple aim of improving patient experience, population health, care team well-being, health care costs,...
2.
Sasseville M, Leblanc A, Tchuente J, Boucher M, Dugas M, Gisele M, et al.
Syst Rev
. 2023 May;
12(1):78.
PMID: 37143171
Background: The majority of people with a chronic disease (e.g., diabetes, hypertension, COPD) have more than one concurrent condition and are also at higher risk for developing comorbidities in mental...
3.
Sasseville M, Leblanc A, Boucher M, Dugas M, Mbemba G, Tchuente J, et al.
BMJ Open
. 2021 Apr;
11(4):e044437.
PMID: 33820786
Objective: Determine the effectiveness of digital mental health interventions for individuals with a concomitant chronic disease. Design: We conducted a rapid review of systematic reviews. Two reviewers independently conducted study...
4.
Dansereau M, Midavaine E, Begin-Lavallee V, Belkouch M, Beaudet N, Longpre J, et al.
J Neuroinflammation
. 2021 Mar;
18(1):79.
PMID: 33757529
Background: Pain is reported as the leading cause of disability in the common forms of inflammatory arthritis conditions. Acting as a key player in nociceptive processing, neuroinflammation, and neuron-glia communication,...
5.
Besserer-Offroy E, Tetreault P, Brouillette R, Rene A, Murza A, Fanelli R, et al.
Data Brief
. 2020 Jul;
31:105884.
PMID: 32637491
Neurotensin (NT) is a tridecapeptide displaying interesting antinociceptive properties through its action on its receptors, NTS1 and NTS2. Neurotensin-like compounds have been shown to exert better antinociceptive properties than morphine...
6.
Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog
Tetreault P, Besserer-Offroy E, Brouillette R, Rene A, Murza A, Fanelli R, et al.
Eur J Pharmacol
. 2020 Jun;
882:173174.
PMID: 32534076
Neurotensin (NT) exerts naloxone-insensitive antinociceptive action through its binding to both NTS and NTS receptors and NT analogs provide stronger pain relief than morphine on a molecular basis. Here, we...
7.
Page G, Lacasse A, Beaudet N, Choiniere M, Deslauriers S, Diatchenko L, et al.
Pain Rep
. 2020 Feb;
5(1):e799.
PMID: 32072095
Introduction: The neurobiological mechanisms underlying recovery from or persistence of low back pain (LBP) remain misunderstood, limiting progress toward effective management. We have developed an innovative two-tier design to study...
8.
Barriere D, Midavaine E, Dore-Savard L, Kirby K, Tremblay L, Beaudoin J, et al.
Sci Rep
. 2020 Feb;
10(1):2979.
PMID: 32060338
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
9.
Barriere D, Midavaine E, Dore-Savard L, Kirby K, Tremblay L, Beaudoin J, et al.
Sci Rep
. 2019 Dec;
9(1):20155.
PMID: 31882872
Improvements in the survival of breast cancer patients have led to the emergence of bone health and pain management as key aspects of patient's quality of life. Here, we used...
10.
Barriere D, Noll C, Roussy G, Lizotte F, Kessai A, Kirby K, et al.
Sci Rep
. 2018 Jan;
8(1):424.
PMID: 29323186
The epidemic of type 2 diabetes mellitus (T2DM) is fueled by added fructose consumption. Here, we thus combined high-fat/high-fructose diet, with multiple low-dose injections of streptozotocin (HF/HF/Stz) to emulate the...